Safety/Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of LCZ696 in Patients With Stable Heart Failure
NCT00913653 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2020-12-19
Summary
This study assess the safety/tolerability, PK/PD of LCZ696 in patients with stable heart failure.
Conditions
Interventions
- DRUG
-
LCZ696
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-05-31
- Primary Completion
- 2009-07-31
Countries
- Russia
Study Locations
More Related Trials
-
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
NCT03066804 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
NCT02678312 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan.
NCT03909295 ·Status: TERMINATED ·Phase: PHASE3
-
Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life Setting
NCT02690974 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Oral CK-1827452 in Patients With Stable Heart Failure
NCT00941681 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event
NCT02661217 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy
NCT04164732 ·Status: COMPLETED ·Phase: PHASE2
-
Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.
NCT02768298 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes.
NCT02887183 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
NCT02924727 ·Status: COMPLETED ·Phase: PHASE3
-
Six Months Clinical and Echocardiographic Outcome of ARNI LCZ696 Therapy in HFrEF Patients
NCT03816306 ·Status: COMPLETED
-
Open-label Extension Study for CLCZ696G2301 (PARADISE-MI)
NCT04637555 ·Status: WITHDRAWN ·Phase: PHASE3
-
Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient Department
NCT06683053 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of CLR325 in Chronic Stable Heart Failure Patients.
NCT02696967 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
NCT06979362 ·Status: RECRUITING ·Phase: PHASE2
-
A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 Study
NCT06149104 ·Status: COMPLETED ·Phase: PHASE3
-
PAtient RegisTry Assessing Effectiveness and Safety of HEart Failure treatmeNt With LCZ696 acrOss CaNada
NCT02957409 ·Status: COMPLETED
-
Safety, PK, and Efficacy of Omecamtiv Mecarbil in Japanese Subjects With Heart Failure With Reduced Ejection Fraction
NCT02695420 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure
NCT07218627 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)
NCT00090259 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Furosemide Withdraw in Stable Chronic Heart Failure Outpatients
NCT02689180 ·Status: UNKNOWN ·Phase: PHASE3
-
v4 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-491
NCT03447990 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF)
NCT02389933 ·Status: NO_LONGER_AVAILABLE
-
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
NCT02816736 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake
NCT03962101 ·Status: COMPLETED ·Phase: PHASE3